Stay updated on Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Publication of KEYNOTE-122 results is now listed with the citation, and study record dates plus IPD sharing information have been updated. The page references the 2023 Ann Oncol publication and related data-sharing documentation.
    Difference
    0.4%
    Check dated 2025-11-03T20:58:53.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Version bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.
    Difference
    2%
    Check dated 2025-10-06T04:57:52.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:56:12.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:50:45.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T13:24:14.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as expanded drug information for various compounds, while removing several specific disease references and drug classifications.
    Difference
    4%
    Check dated 2025-08-31T11:19:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.